Trial results show compound makes radiotherapy more effective
16 November 2018 | By European Pharmaceutical Review
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
List view / Grid view
Drug Targets
NIAID plan for in-depth tuberculosis research
27 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
Seizures could be stopped and prevented with implanted electronic device
30 August 2018 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
Protein kinase C-alpha inhibitor reverses destructive nephritis
30 July 2018 | By European Pharmaceutical Review
Inhibiting protein kinase C-alpha was shown to be a pivotal step towards restoring the damage done by nephritis...
FDA approves the first drug with an indication for treatment of smallpox
16 July 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox...
Plerixafor may protect against smoke-related COPD symptoms
5 July 2018 | By European Pharmaceutical Review
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury...
Flu’s response to Xofluza explored
26 June 2018 | By European Pharmaceutical Review
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge...
BCG vaccine leads to long-term blood sugar improvement in type 1 diabetes
22 June 2018 | By European Pharmaceutical Review
A study has found a novel mechanism underlying stable, durable blood sugar control...
Researchers find combination can enhance ipilimumab immunotherapy
18 June 2018 | By European Pharmaceutical Review
Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open...
SMC approves Xermelo for carcinoid syndrome diarrhoea
13 June 2018 | By European Pharmaceutical Review
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
Better outcomes for patients using single-pill combination for hypertension
12 June 2018 | By European Pharmaceutical Review
Findings may represent simple and potentially low-cost intervention...
Talazoparib shows promise for early-stage BRCA+ breast cancer patients
5 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review), zae
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
Immunosuppressant drugs may protect against Parkinson’s
1 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
People who take immunosuppressants are less likely to develop Parkinson's disease...
Ibrutinib may benefit glioblastoma patients
31 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
An FDA-approved drug for lymphoma and leukaemia may also help treat the most common - and deadliest type of brain tumour...
FDA accepts Larotrectinib New Drug Application and Grants Priority Review
31 May 2018 | By European Pharmaceutical Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
Follow: